BodyFriend
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BodyFriend - overview
Established
2007
Location
Seoul, -, South Korea
Primary Industry
Consumer Products
About
BodyFriend Co. , Ltd. , based in South Korea, specializes in health and wellness solutions, focusing on advanced massage chairs and healthcare robots that enhance physical well-being and comfort for various consumers and commercial clients. Founded in 2007 in Seoul, South Korea, BodyFriend Co.
, Ltd. focuses on developing innovative health and wellness products. The company has completed 6 deals, with its most recent funding round being a Secondary Buyout of KRW 420 billion in November 2021, which raised the total amount to KRW 420 billion. Its notable investors include Hahn & Brothers, Harim Group, OK Capital, and Stonebridge Capital.
BodyFriend Co. , Ltd. specializes in health and wellness solutions, primarily focusing on advanced massage chairs and healthcare robots designed to enhance physical well-being and comfort. Their flagship products include the Eden Robot, which utilizes advanced technology to provide personalized massage experiences, and the Medical Pharaoh, a medically oriented massage chair that offers therapeutic benefits.
These products cater to individual consumers seeking personal relaxation and comfort at home, as well as commercial establishments such as spas and wellness centers aiming to provide high-quality services. BodyFriend operates in several geographical markets, including a significant presence in South Korea, with expansions into international markets across Asia and beyond. For the most recent year, BodyFriend reported revenues of KRW 320,518,821. 9, with an EBITDA of KRW 16,545,050.
4. The company's revenue is generated through direct-to-consumer sales and strategic partnerships with retailers and wellness businesses, utilizing a structured transaction model that includes equipment sales, rental services, and subscription-based maintenance plans for its products. BodyFriend aims to leverage its recent funding to enhance its product lineup and expand its market presence. The company is working on developing new products, including updated versions of its massage chairs and healthcare robots, with expected releases in the coming years.
BodyFriend plans to further penetrate Asian markets and explore opportunities in Europe and North America by 2024. The strategic partnerships established through the recent funding will support these initiatives, enabling the company to enhance its offerings and meet the growing demand for health and wellness solutions.
Current Investors
Korea Investment Partners, Mirae Asset Venture Investment, Stonebridge Capital
Primary Industry
Consumer Products
Sub Industries
Household Appliances
Website
http://www.bodyfriend.co.kr
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
BodyFriend - timeline of key events
BodyFriend - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 34,083,478,382 | 65,215,711,750 | 78,524,460,758 | 14,381,697,874 | 263,558,394,312 | 366,462,565,694 | 412,979,370,044 | 450,476,672,197 | 480,261,996,547 | 555,650,547,537 | 591,312,915,481 | 522,027,772,409 | - | - | - |
| % Revenue Growth (YoY) | - | 91.3% | 20.4% | (81.7%) | 1732.6% | 39.0% | 12.7% | 9.1% | 6.6% | 15.7% | 6.4% | (11.7%) | - | - | - |
| EBITDA (USD) | 6,371,983,021 | 15,547,240,051 | 18,966,609,493 | 30,440,841,042 | 61,923,026,499 | 94,531,784,473 | 95,865,154,555 | 67,606,111,257 | 62,912,100,607 | 76,817,954,781 | 106,355,968,337 | 62,087,618,087 | - | - | - |
| Operating Income (USD) | 6,128,930,975 | 15,102,544,200 | 18,104,494,583 | 28,388,512,528 | 56,596,220,768 | 87,095,783,610 | 83,379,693,555 | 50,947,669,257 | 41,159,786,607 | 52,247,000,781 | 68,523,844,337 | 24,121,990,087 | - | - | - |
| Operating Margin | 18.0% | 23.2% | 23.1% | 197.4% | 21.5% | 23.8% | 20.2% | 11.3% | 8.6% | 9.4% | 11.6% | 4.6% | - | - | - |
| % EBITDA Margin | 18.7% | 23.8% | 24.2% | 211.7% | 23.5% | 25.8% | 23.2% | 15.0% | 13.1% | 13.8% | 18.0% | 11.9% | - | - | - |
| NET Income (USD) | 5,817,440,594 | 12,790,718,131 | 12,862,145,553 | 18,598,839,395 | 48,816,077,585 | 69,405,027,061 | 61,876,383,686 | 57,033,393,784 | 34,339,153,333 | 40,526,176,207 | 57,860,105,980 | 38,893,833,381 | - | - | - |
| % Net Margin | 17.1% | 19.6% | 16.4% | 129.3% | 18.5% | 18.9% | 15.0% | 12.7% | 7.2% | 7.3% | 9.8% | 7.5% | - | - | - |
BodyFriend - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | BodyFriend | - | ||||||||
| Buyout | Completed | BodyFriend | - | ||||||||
| Private Placement/Follow on | Completed | BodyFriend | - | ||||||||
| Private Placement/Follow on | Completed | BodyFriend | - | ||||||||
| Buyout | Completed | BodyFriend | - |
Displaying 1 - 5 of 6
BodyFriend - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.